Literature DB >> 19171207

The management of paroxysmal nocturnal hemoglobinuria: recent advances in diagnosis and treatment and new hope for patients.

Neal S Young1, Gabrielle Meyers, Hubert Schrezenmeier, Peter Hillmen, Anita Hill.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19171207      PMCID： PMC3402209          DOI： 10.1053/j.seminhematol.2008.11.004

Source DB:  PubMed          Journal:  Semin Hematol        ISSN： 0037-1963            Impact factor:   3.851


× No keyword cloud information.
  17 in total

Review 1.  Application of flow cytometry to the diagnosis of paroxysmal nocturnal hemoglobinuria.

Authors:  S J Richards; A C Rawstron; P Hillmen
Journal:  Cytometry       Date:  2000-08-15

2.  Paroxysmal nocturnal hemoglobinuria; a classic description by Paul Strübling in 1882, and a bibliography of the disease.

Authors:  W H CROSBY
Journal:  Blood       Date:  1951-03       Impact factor: 22.113

3.  The use of monoclonal antibodies and flow cytometry in the diagnosis of paroxysmal nocturnal hemoglobinuria.

Authors:  S E Hall; W F Rosse
Journal:  Blood       Date:  1996-06-15       Impact factor: 22.113

4.  Inhibition of complement activity by humanized anti-C5 antibody and single-chain Fv.

Authors:  T C Thomas; S A Rollins; R P Rother; M A Giannoni; S L Hartman; E A Elliott; S H Nye; L A Matis; S P Squinto; M J Evans
Journal:  Mol Immunol       Date:  1996-12       Impact factor: 4.407

5.  Variations in the red cells in paroxysmal nocturnal haemoglobinuria.

Authors:  W F Rosse
Journal:  Br J Haematol       Date:  1973-03       Impact factor: 6.998

6.  Superior growth of glycophosphatidy linositol-anchored protein-deficient progenitor cells in vitro is due to the higher apoptotic rate of progenitors with normal phenotype in vivo.

Authors:  Guibin Chen; Martha Kirby; Weihua Zeng; Neal S Young; Jaroslaw P Maciejewski
Journal:  Exp Hematol       Date:  2002-07       Impact factor: 3.084

7.  Primary prophylaxis with warfarin prevents thrombosis in paroxysmal nocturnal hemoglobinuria (PNH).

Authors:  Claire Hall; Stephen Richards; Peter Hillmen
Journal:  Blood       Date:  2003-07-31       Impact factor: 22.113

8.  Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria.

Authors:  Peter Hillmen; Claire Hall; Judith C W Marsh; Modupe Elebute; Michael P Bombara; Beth E Petro; Matthew J Cullen; Stephen J Richards; Scott A Rollins; Christopher F Mojcik; Russell P Rother
Journal:  N Engl J Med       Date:  2004-02-05       Impact factor: 91.245

9.  Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria.

Authors:  Peter Hillmen; Petra Muus; Ulrich Dührsen; Antonio M Risitano; Jörg Schubert; Lucio Luzzatto; Hubert Schrezenmeier; Jeffrey Szer; Robert A Brodsky; Anita Hill; Gerard Socié; Monica Bessler; Scott A Rollins; Leonard Bell; Russell P Rother; Neal S Young
Journal:  Blood       Date:  2007-08-16       Impact factor: 22.113

10.  Natural history of paroxysmal nocturnal hemoglobinuria.

Authors:  P Hillmen; S M Lewis; M Bessler; L Luzzatto; J V Dacie
Journal:  N Engl J Med       Date:  1995-11-09       Impact factor: 91.245
View more
  7 in total

1.  T Cell Transcriptomes from Paroxysmal Nocturnal Hemoglobinuria Patients Reveal Novel Signaling Pathways.

Authors:  Kohei Hosokawa; Sachiko Kajigaya; Keyvan Keyvanfar; Wangmin Qiao; Yanling Xie; Danielle M Townsley; Xingmin Feng; Neal S Young
Journal:  J Immunol       Date:  2017-06-19       Impact factor: 5.422

2.  Recurrent small bowel ischemia in a patient with paroxysmal nocturnal hemoglobinuria.

Authors:  Joana Torres; Bénédicte De Vroey; Marie-Pierre Noël; Bertrand Notteghem; Jean-Frédéric Colombel
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-05-04       Impact factor: 46.802

3.  Baseline characteristics and disease burden in patients in the International Paroxysmal Nocturnal Hemoglobinuria Registry.

Authors:  Hubert Schrezenmeier; Petra Muus; Gérard Socié; Jeffrey Szer; Alvaro Urbano-Ispizua; Jaroslaw P Maciejewski; Robert A Brodsky; Monica Bessler; Yuzuru Kanakura; Wendell Rosse; Gus Khursigara; Camille Bedrosian; Peter Hillmen
Journal:  Haematologica       Date:  2014-01-31       Impact factor: 9.941

Review 4.  Paroxysmal nocturnal haemoglobinuria.

Authors:  Anita Hill; Amy E DeZern; Taroh Kinoshita; Robert A Brodsky
Journal:  Nat Rev Dis Primers       Date:  2017-05-18       Impact factor: 52.329

Review 5.  Halting targeted and collateral damage to red blood cells by the complement system.

Authors:  M Jalink; E C W de Boer; D Evers; M Q Havinga; J M I Vos; S Zeerleder; M de Haas; I Jongerius
Journal:  Semin Immunopathol       Date:  2021-06-30       Impact factor: 9.623

6.  Baseline clinical characteristics and disease burden in patients with paroxysmal nocturnal hemoglobinuria (PNH): updated analysis from the International PNH Registry.

Authors:  Hubert Schrezenmeier; Alexander Röth; David J Araten; Yuzuru Kanakura; Loree Larratt; Jamile M Shammo; Amanda Wilson; Gilda Shayan; Jaroslaw P Maciejewski
Journal:  Ann Hematol       Date:  2020-05-10       Impact factor: 3.673

Review 7.  Circadian Clock and Complement Immune System-Complementary Control of Physiology and Pathology?

Authors:  Pooja Shivshankar; Baharan Fekry; Kristin Eckel-Mahan; Rick A Wetsel
Journal:  Front Cell Infect Microbiol       Date:  2020-08-14       Impact factor: 5.293
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.